Scientech Research LLC’s BioNexus Gene Lab BGLC Stock Holding History

Scientech Research LLC’s Portfolio BGLC Stock Details BGLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,080	Closed	-$3.02K	–	583
2024 Q4	$3.02K	Buy	1,080 +41	+4%	+$135	﹤0.01%	548
2024 Q3	$4.62K	Buy	+1,039	New	+$4.67K	﹤0.01%	589

Other funds holding BGLC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Scientech Research LLC's BGLC Position: Q1 2025 in Review

Scientech Research LLC sold out of BioNexus Gene Lab (BGLC) in Q1 2025, closing a stake of 1,080 shares — an estimated $3.02K sold.

Scientech Research LLC first reported a position in BGLC in Q3 2024 and held it in 2 quarters. The position peaked at $4.62K in Q3 2024. 3 funds tracked by Wall St. Rank hold BGLC as of Q1 2025.

Scientech Research LLC reported no remaining BioNexus Gene Lab position as of Q1 2025 after selling out during the quarter.
Scientech Research LLC sold 1,080 BioNexus Gene Lab shares in Q1 2025, an estimated $3.02K.
Scientech Research LLC first reported a position in BioNexus Gene Lab in Q3 2024 and held it in 2 quarters.
Scientech Research LLC's BioNexus Gene Lab position peaked at $4.62K in Q3 2024.
3 funds tracked by Wall St. Rank held BioNexus Gene Lab as of Q1 2025.

Based on Scientech Research LLC's 13F filing for Q1 2025, filed 15 May 2025.